Focused on Your Health

Founded in 2010, Althera develops innovative patient focused medicines.

Althera’s Rosuvastatin/Ezetimibe tablets is already approved and available to patients in more than 28 countries worldwide including United States and all major European markets.

US Healthcare Professionals can learn more about Roszet® at www.roszet.com. Please read full Prescribing information at roszet.com/pi.

Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients next year.